PM 📈 Philip Morris International - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7181721090
PM: Cigarettes, Heat-not-burn, Vapor, Oral Nicotine, Wellness, Healthcare
Philip Morris International Inc. is a leading tobacco company that is undergoing a significant transformation, driven by its vision to deliver a smoke-free future. The company is actively working to evolve its portfolio, diversifying its offerings to include a range of products beyond the traditional tobacco and nicotine sector. This strategic shift is aimed at positioning the company for long-term growth and success, while also addressing the changing preferences and needs of its customers.
The company's product portfolio is currently comprised of a mix of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products. These smoke-free products are primarily sold under the IQOS and ZYN brands, which have gained significant traction in the market. In addition to its tobacco and nicotine products, Philip Morris International Inc. also offers a range of consumer accessories, such as lighters and matches, as well as wellness and healthcare products. This diversified portfolio is designed to provide customers with a range of choices, while also generating revenue streams for the company.
Philip Morris International Inc. has a long history, dating back to its incorporation in 1987. The company is headquartered in Stamford, Connecticut, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol PM. With a global presence and a significant customer base, the company is well-positioned to drive growth and innovation in the tobacco and related industries. For more information, investors and customers can visit the company's website at https://www.pmi.com. The company's common stock is traded under the ISIN code US7181721090, and is classified under the GICS Sub Industry: Tobacco, providing a framework for investors to evaluate its performance and prospects.
Additional Sources for PM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PM Stock Overview
Market Cap in USD | 193,141m |
Sector | Consumer Defensive |
Industry | Tobacco |
GiC Sub-Industry | Tobacco |
IPO / Inception | 2008-03-17 |
PM Stock Ratings
Growth 5y | 78.9% |
Fundamental | 65.0% |
Dividend | 62.9% |
Rel. Strength Industry | 158 |
Analysts | 4/5 |
Fair Price Momentum | 136.01 USD |
Fair Price DCF | 167.06 USD |
PM Dividends
Dividend Yield 12m | 3.18% |
Yield on Cost 5y | 5.95% |
Annual Growth 5y | 2.16% |
Payout Consistency | 99.1% |
PM Growth Ratios
Growth Correlation 3m | 52.1% |
Growth Correlation 12m | 94% |
Growth Correlation 5y | 88.3% |
CAGR 5y | 13.33% |
CAGR/Mean DD 5y | 1.83 |
Sharpe Ratio 12m | 1.52 |
Alpha | 19.48 |
Beta | 0.69 |
Volatility | 21.23% |
Current Volume | 10267.4k |
Average Volume 20d | 5047k |
As of December 21, 2024, the stock is trading at USD 124.22 with a total of 10,267,415 shares traded.
Over the past week, the price has changed by -3.80%, over one month by -5.69%, over three months by +3.17% and over the past year by +35.03%.
Yes, based on ValueRay Fundamental Analyses, Philip Morris International (NYSE:PM) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 65.03 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PM as of December 2024 is 136.01. This means that PM is currently overvalued and has a potential downside of 9.49%.
Philip Morris International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy PM.
- Strong Buy: 6
- Buy: 4
- Hold: 3
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, PM Philip Morris International will be worth about 148 in December 2025. The stock is currently trading at 124.22. This means that the stock has a potential upside of +19.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 136.2 | 9.6% |
Analysts Target Price | 111.5 | -10.2% |
ValueRay Target Price | 148 | 19.2% |